MSCT评估粪石性小肠梗阻保守治疗粪石通过性的价值
回顾性纳入72例粪石性小肠梗阻患者,治疗前1天内行全腹MSCT,由两名放射科医生观察测量,按保守治疗后粪石能否通过分为通过组与非通过组。粪石表现、最大HU值、肠壁厚度、肠系膜浑浊、肠系膜积液、腹腔积液在两组间有统计学差异。粪石表现和肠系膜浑浊是保守治疗失败的独立危险因素,两者同时满足时特异度93.8%、PPV 76.9%,敏感度降至41.7%、NPV 76.3%。
要点
- 粪石表现与肠系膜浑浊是保守治疗能否通过的独立预测因素。
- 两者同时满足时特异度93.8%、PPV 76.9%,敏感度41.7%。
- MSCT可提供影像依据,辅助临床选择保守或手术干预。
核心结论
- MSCT观察粪石表现及肠系膜浑浊等征象,对评估保守治疗能否通过粪石有重要临床价值。
- 粪石表现和肠系膜浑浊是保守治疗失败的独立危险因素。
- 两征象同时满足时特异度93.8%和PPV 76.9%提高,敏感度41.7%降低,NPV 76.3%无明显变化。
研究设计与样本
- 本研究为回顾性研究,纳入72例粪石性小肠梗阻患者,平均年龄52.2±16.2岁,男32例、女40例,年龄范围13-81岁。
- 所有患者均在治疗前1天内接受全腹MSCT扫描,由两名放射科医生观察和测量CT图像。
- 按保守治疗后粪石能否通过分为通过组与非通过组。
- 统计分析采用Student's t检验、Pearson卡方检验、Fisher精确检验、Logistic线性回归和ROC曲线。
关键影像表现/征象
- 两组在粪石表现、粪石最大HU值、肠壁厚度、肠系膜浑浊、肠系膜积液和腹腔积液方面存在统计学差异(P=0.002、0.024、0.017、0.006、0.021和0.030)。
- 粪石表现是影响保守治疗能否通过的独立危险因素。
- 肠系膜浑浊是影响保守治疗能否通过的独立危险因素。
诊断标准与关键数值
- 粪石表现和肠系膜浑浊同时满足评估保守治疗失败时,敏感度41.7%、特异度93.8%、PPV 76.9%、NPV 76.3%。
临床应用与阅片要点
- 阅片时应重点观察粪石表现和肠系膜浑浊,两者同时满足时提示保守治疗失败风险高。
- 联合其他CT征象(粪石最大HU值、肠壁厚度、肠系膜积液、腹腔积液)可提高评估全面性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To explore the multi-slice spiral computed tomography (MSCT) imaging characteristics of patients with bezoars-induced small bowel obstruction (BI-SBO) to evaluate the risk of conservative treatment.
MATERIALS AND METHODS: This retrospective study included 72 patients with BI-SBO who underwent whole-abdominal MSCT scan within 1 day before treatment. The patients were classified as the non-pass group and pass group depending on whether bezoar can pass after conservative treatment. The CT images were observed and measured by two radiologists. Statistical analysis was performed by using Student's t test, Pearson's chi-squared test, Fisher's exact test, Logistic linear regression, and receiver operating characteristic curve (ROC).
RESULTS: The study population consisted of 72 patients with a mean age of 52.2 ± 16.2 years (32 men and 40 women with an age range of 13-81 years). There were statistical differences between the two groups in the bezoar appearance, maximum HU of bezoar, thickness of intestinal wall, mesenteric haziness, mesenteric fluid, and peritoneal fluid (P = 0.002, 0.024, 0.017, 0.006, 0.021, and 0.030). The appearance of bezoar and mesenteric haziness is independent risk factors affecting whether bezoar can be passed by the conservative treatment. Sensitivity (41.7%) was decreased, NPV (76.3%) was not significantly changed, specificity (93.8%) and PPV (76.9%) were improved when both parameters were met to assess failure of conservative treatment.
CONCLUSION: The observation of important signs by MSCT and its reconstruction technology is of great clinical value in evaluating the passability of bezoar by conservative treatment, and which can provide radiographic basis for clinical treatment selection.
引用
- Gao, Hua, Meng, et al. The value of MSCT in evaluating the passability of bezoar by conservative treatment for bezoars-induced small bowel obstruction. Abdom Radiol (NY). 2022. PMID: 36242605. doi:10.1007/s00261-022-03700-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。